Literature DB >> 19707478

Successful Primary Treatment of a Hydatidiform Mole with Methotrexate and EMA/CO.

M De Vos1, M Leunen, C Fontaine, Ph De Sutter.   

Abstract

Background. The preferred treatment method of most hydatidiform moles is suction aspiration. In rare circumstances uterine abnormalities may preclude surgical treatment. Case. We report a case of complete molar pregnancy successfully treated with methotrexate followed by EMA/CO. A 38-year-old woman with a complete hydatidiform mole and multiple uterine fibroids underwent a failed attempt at suction aspiration. Following treatment with methotrexate, a nonmetastatic persistent trophoblastic tumour developed. Six cycles of EMA/CO led to complete remission. Conclusion. We propose that primary treatment of molar pregnancies with chemotherapy is a useful treatment option in cases where uterine abnormalities interfere with suction aspiration.

Entities:  

Year:  2009        PMID: 19707478      PMCID: PMC2729468          DOI: 10.1155/2009/454161

Source DB:  PubMed          Journal:  Case Rep Med


  6 in total

1.  Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy.

Authors:  J A Tidy; A M Gillespie; N Bright; C R Radstone; R E Coleman; B W Hancock
Journal:  Gynecol Oncol       Date:  2000-09       Impact factor: 5.482

Review 2.  Chorionic tumors.

Authors:  R S Berkowitz; D P Goldstein
Journal:  N Engl J Med       Date:  1996-12-05       Impact factor: 91.245

3.  Termination of a molar pregnancy using mifepristone and gemeprost.

Authors:  A Bates; A Pinto; J Evans
Journal:  Br J Obstet Gynaecol       Date:  1994-07

Review 4.  Epidemiology and aetiology of gestational trophoblastic diseases.

Authors:  Andrea Altieri; Silvia Franceschi; Jacques Ferlay; Jennifer Smith; Carlo La Vecchia
Journal:  Lancet Oncol       Date:  2003-11       Impact factor: 41.316

Review 5.  Diagnosis and management of gestational trophoblastic neoplasia.

Authors:  T Y Ng; L C Wong
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-12       Impact factor: 5.237

6.  Initial management of hydatidiform mole.

Authors:  J B Schlaerth; C P Morrow; F J Montz; G d'Ablaing
Journal:  Am J Obstet Gynecol       Date:  1988-06       Impact factor: 8.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.